Recombinant multi-species PTHLH protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PTHLH protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the parathyroid hormone family. This hormone, via its receptor, PTHR1, regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. It is responsible for most cases of humoral hypercalcemia of malignancy, and mutations in this gene are associated with brachydactyly type E2 (BDE2). Alternatively spliced transcript variants have been found for this gene. There is also evidence for alternative translation initiation from non-AUG (CUG and GUG) start sites, downstream of the initiator AUG codon, resulting in nuclear forms of this hormone. [provided by RefSeq, Nov 2013]
The Alternative Names of target: BDE2,HHM,PLP,PTH-like,PTH-rP,PTHLH,PTHR,PTHRP,PTHrP,Parathyroid hormone-like protein (PLP),Parathyroid hormone-related protein,Pthlh,Pthrp

Target products collectionGo to PTHLH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1230-Ag-1/ GM-Tg-hg-SE1230-Ag-2 Human PTHLH protein Human
GM-Tg-rg-SE1230-Ag-1/ GM-Tg-rg-SE1230-Ag-2 Rat PTHLH protein Rat
GM-Tg-mg-SE1230-Ag-1/ GM-Tg-mg-SE1230-Ag-2 Mouse PTHLH protein Mouse
GM-Tg-cynog-SE1230-Ag-1/ GM-Tg-cynog-SE1230-Ag-2 Cynomolgus/Rhesus macaque PTHLH protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1230-Ag-1/ GM-Tg-felg-SE1230-Ag-2 Feline PTHLH protein Feline
GM-Tg-cang-SE1230-Ag-1/ GM-Tg-cang-SE1230-Ag-2 Canine PTHLH protein Canine
GM-Tg-bovg-SE1230-Ag-1/ GM-Tg-bovg-SE1230-Ag-2 Bovine PTHLH protein Bovine
GM-Tg-equg-SE1230-Ag-1/ GM-Tg-equg-SE1230-Ag-2 Equine PTHLH protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1230-Ag-1/ GM-Tg-hg-SE1230-Ag-2; GM-Tg-rg-SE1230-Ag-1/ GM-Tg-rg-SE1230-Ag-2;
GM-Tg-mg-SE1230-Ag-1/ GM-Tg-mg-SE1230-Ag-2; GM-Tg-cynog-SE1230-Ag-1/ GM-Tg-cynog-SE1230-Ag-2;
GM-Tg-felg-SE1230-Ag-1/ GM-Tg-felg-SE1230-Ag-2; GM-Tg-cang-SE1230-Ag-1/ GM-Tg-cang-SE1230-Ag-2;
GM-Tg-bovg-SE1230-Ag-1/ GM-Tg-bovg-SE1230-Ag-2; GM-Tg-equg-SE1230-Ag-1/ GM-Tg-equg-SE1230-Ag-2
Products Name PTHLH protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PTHLH
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PTHLH protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.